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Figure 1. Gallium-67 citrate whole-body scintigraphy performed
prior to treatment. After intravenous injection of 74 MBq of 
gallium-67 citrate, the 48-hour delayed image shows increased
tracer accumulation in bilateral external ears (more markedly on
the left side), neck, mediastinum and bilateral pulmonary hili
(arrows).
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Relapsing polychondritis is a rare multisystem autoim-
mune disorder of unknown origin. The cartilaginous
tissues are the primary targets of destruction, most
commonly the ears, nose, joints and respiratory sys-
tem. Gallium-67 citrate scintigraphy (gallium scan) is
a sensitive tool for evaluating inflammatory activity.
We present a case of polychondritis and assess the
value of gallium scanning in detecting inflammation
and monitoring a patient’s response to treatment.
CASE PRESENTATION
A 57-year-old man complained of a 10-day history of
low-grade fever and progressive pain, swelling and
erythema of both external ears. Laboratory data
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We present a 57-year-old man who had low-grade fever and painful, swollen and erythematous
ears. Gallium-67 citrate scintigraphy (gallium scan) performed prior to the commencement of treat-
ment showed increased gallium uptake in bilateral external ears, neck, mediastinum and bilateral
pulmonary hili. The results of ultrasonography of both ears were compatible with the diagnosis of
chondritis. The patient’s clinical condition and laboratory data improved after a course of non-
steroidal anti-inflammatory drugs and steroids. Gallium scan performed after treatment showed
a diminished uptake in the external ears, neck, and mediastinum. Gallium scintigraphy is a valuable
tool for evaluating inflammatory activity and monitoring therapeutic response in patients with
relapsing polychondritis.
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showed leukocytosis (white blood cells, 21,550/mm3;
neutrophils/lymphocytes, 89.1%/6.5%), thrombo-
cytosis (platelet count, 707×103/mm3), elevated C-reac-
tive protein (CRP) level of 24.7mg/dL (normal range,
<0.8mg/dL), and erythrocyte sedimentation rate (ESR)
>140mm/hour (normal range in males, 0–15mm/hr).
A whole-body scan was performed 48 hours after
intravenous injection of 74 MBq (2 mCi) gallium-67
citrate and demonstrated increased gallium-67 citrate
uptake in both ears (especially on the left side), neck,
mediastinum and bilateral pulmonary hili (Figure 1).
An inflammatory process involving the external ears,
trachea and central bronchi was highly suspected. No
histologic study of the external ears or the respiratory
tract was performed because of the patient’s refusal.
Chest radiography showed normal appearance of the
mediastinum and bilateral pulmonary hili. Doppler
ultrasonography of both ears revealed swelling of the
cartilage of the external ears, pericartilage edematous
change and significant hypervascularity, which was
compatible with chondritis (Figure 2).
The patient recovered rapidly following a 1-week
course of a nonsteroidal anti-inflammatory drug
(cataflam) and steroids (methasone and prednisolone).
Laboratory investigations revealed a CRP level of
0.27 mg/dL, a platelet count of 292 × 103/mm3 and
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Figure 2. Ultrasonography of both external ears performed prior to therapy shows cartilage swelling of both ears. (A) Power Doppler
ultrasonography shows hypervascularity over the anterior-upper, upper and middle portions of the left ear. The cartilage-free lower lobe
was spared. (B) Power Doppler ultrasonography of the right external ear shows a similar sonographic pattern to that of the left external
ear. The sonographic findings in bilateral ears were compatible with the pathophysiology of chondritis.
normalizing leukocytosis (white blood cells, 16,700/
mm3; neutrophils/lymphocytes, 74.5%/18.1%). A
gallium-67 citrate whole-body scan performed 1 month
later showed diminished gallium uptake in bilateral
external ears, the nasal region, neck, mediastinum, and
bilateral pulmonary hili (Figure 3), compatible with
clinical remission. Doppler ultrasonography of both
ears also revealed normalized vascularity (Figure 4).
The patient remained afebrile and pain-free over the
17-month follow-up period.
DISCUSSION
Relapsing polychondritis is a rare multisystem auto-
immune disorder of unknown origin. The cartilagi-
nous tissues are the primary targets of destruction,
but the immune damage can spread to involve non-
cartilaginous tissues like the kidney and blood ves-
sels [1]. Relapsing polychondritis can be diagnosed
when one or more signs of McAdam [2] are present
along with histologic confirmation, or when chondri-
tis is present in two or more separate anatomic lesions
and is responsive to steroids [3]. Since two or more
sites of chondritis and a response to steroids are nec-
essary to make a diagnosis, a convenient examination
with abilities to evaluate whole-body inflammatory
activity and to monitor the effect of treatment is pre-
ferred. Pre- and posttreatment gallium-67 whole body
scintigraphy is a suitable examination to aid diagnosis.
In patients with relapsing polychondritis, the auri-
cles, larynx and upper trachea are the most frequent-
ly affected sites [2,4,5]. Gallium scanning, a sensitive
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Figure 3. Gallium-67 citrate whole-body scintigraphy performed
1 month after treatment with a nonsteroidal anti-inflammatory
drug and steroids. Scintigraphy was performed 48 hours after
intravenous injection of 74 MBq of gallium-67 citrate. Diminished
tracer uptake in bilateral external ears, neck, mediastinum and
bilateral pulmonary hili was noted when compared with the pre-
vious imaging study shown in Figure 1.
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Figure 4. Ultrasonography of both external ears performed after therapy shows normalized vascularity as compared with Figure 2.
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indicator of active inflammation, could reflect inflam-
matory activity prior to any morphologic change. In
addition, the ability to perform whole-body imaging
within an acceptable period of about half an hour
makes gallium scanning a convenient examination to
simultaneously evaluate inflammation in different
systems and at different sites, which is not uncommon
in relapsing polychondritis. Auricular chondritis in
polychondritis patients may be unilateral or bilateral,
and the onset of auricular disease can be acute or sub-
acute. The inflammatory status may be different in the
ears due to the heterogeneous nature of the disease
presentation. Gallium-67 avidity has been reported
to be correlated with inflammatory activity [6,7]. In our
case, the gallium-67 avidity in the right ear was lower
than that in the left ear, which may reflect more active
inflammation in the left ear than in the right ear. Ultra-
sonography of the ears showed hypervascularity in
both external ears, but no difference in inflammatory
activity between the ears. In contrast, gallium-67 scan-
ning clearly demonstrated the different amount of
tracer uptake between the ears. Moreover, single pho-
ton emission computed tomography can offer addi-
tional localization information as well as good spatial
resolution to identify inflammatory sites [8].
In areas like the larynx and upper trachea, com-
puted tomography (CT) may provide excellent anato-
mic information, including circumferential thickening
or deformity of cricoid or tracheal cartilage and edema,
fibrosis, or ossification of soft tissues [9,10]. However,
the inflammatory process may fluctuate and precede
morphologic changes and development of symptoms,
and this can result in an unremarkable CT scan despite
active inflammation [11,12]. Real-time power Doppler
ultrasonography can readily detect active inflamma-
tion, seen as increased blood flow [13]. However,
deep cartilage structures in the lower trachea and
bronchi cannot be easily detected by conventional
ultrasonography.
A patient’s clinical condition and inflammatory
markers are usually used to monitor their treatment
response. Gallium scanning is another reliable and
objective method to evaluate the effect of treatment
in inflammatory diseases. Gallium scans show good
correlation with treatment response in inflammatory
disease, which may be associated with lactoferrin [14].
The changes in gallium uptake seen in this case were
consistent with clinical improvement and normalizing
laboratory data, indicating that gallium scans may be
used to evaluate treatment responses. Okuyama et al
[15] reported similar findings in a patient with relaps-
ing polychondritis, in whom the abnormal increased
gallium uptake in the neck disappeared after steroid
therapy. Gallium-67 scanning has also been reported
to play a role in monitoring therapeutic effects in in-
flammatory pulmonary disease [16,17], retroperitoneal
fibrosis [18], lupus nephritis [19], Wegener’s granulo-
matosis [20], and chronic sarcoid myopathy [21].
CT can be used to assess anatomic changes, but has
not been reported to be useful for evaluating treatment
responses in relapsing polychondritis patients. One of
the possible reasons for this is that the resolution of
morphologic changes on CT scans lags behind treat-
ment response and clinical improvement [22]. This is
due to the fact that, once fibrosis or cartilage ring de-
struction occurs, it may never or take a long time to
return to normal, despite the absence of inflammatory
activity [23]. Power Doppler ultrasonography may
reveal normalized blood flow in inflamed sites after
effective treatment, as seen in our case. Again, conven-
tional ultrasonography has a limitation in assessing
deep cartilage structures.
In our case, histopathologic evidence of chondritis
in the mediastinum was not obtained. Although the
increased gallium uptake in the neck and mediastinum
could be due to chondritis in the trachea and central
bronchi, mediastinal tumors (for example, those in
patients with mediastinal Hodgkin’s disease, non-
Hodgkin’s lymphoma, or metastasis), infection (for
example tuberculosis), and sarcoidosis, as well as radi-
ation mediastinitis, may also cause intense gallium
uptake in the mediastinum and should be taken into
consideration. There was no history of malignancy or
radiation to the thorax in this case. During the 17-month
follow-up period, the patient showed no symptoms
or signs related to mediastinal malignancy, sarcoido-
sis or mycobacterial infection. Furthermore, this pa-
tient had a normal chest radiograph, which makes
the diagnosis of sarcoidosis or mycobacterial infec-
tion less likely. Although there was no pathohistologic
evidence, given the patient’s recovery was correlated
with gallium-67 scintigraphic changes, a subclinical
inflammatory process involving the trachea and central
bronchi is the most likely explanation for the gallium-
avid regions in the neck and mediastinum.
Although gallium-67 citrate is readily available in
practice, its shortfalls include a less well-known up-
take mechanism in inflammation, suboptimal physical
Gallium scan in relapsing polychondritis
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characteristics for imaging, and delayed imaging up to 
48 hours after injection due to the slow clearance of
background radioactivity. Other radiopharmaceuticals
used to evaluate inflammation, such as 111In-oxine/
99mTc-hexamethylpropylenamine oxime-labeled leuko-
cytes or 99mTc-labeled granulocytes, may either increase
the specificity or shorten the examination time [24].
However, scintigraphy using these radiopharmaceuti-
cals in patients with relapsing polychondritis has never
been reported, and further investigation is needed.
Bone scintigraphy using 99mTc-methylene diphospho-
nate has been reported to demonstrate inflammatory
cartilage and joints [25–27].
In conclusion, gallium scanning may be a valuable
tool for evaluating inflammatory activity and moni-
toring treatment responses in patients with relapsing
polychondritis.
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